AAAAAA

   
Results: 1-9 |
Results: 9
CLINICAL-SIGNIFICANCE OF CIRCULATING CD44 IN NON-HODGKINS-LYMPHOMA
Authors: RISTAMAKI R JOENSUU H HAGBERG H KALKNER KM JALKANEN S
Citation: R. Ristamaki et al., CLINICAL-SIGNIFICANCE OF CIRCULATING CD44 IN NON-HODGKINS-LYMPHOMA, International journal of cancer, 79(3), 1998, pp. 221-225
STAGE-I NON-HODGKINS-LYMPHOMA TREATED WITH DOXORUBICIN-CONTAINING CHEMOTHERAPY WITH OR WITHOUT RADIOTHERAPY
Authors: VILLIKKA K MUHONEN T RISTAMAKI R TEERENHOVI L JOENSUU H
Citation: K. Villikka et al., STAGE-I NON-HODGKINS-LYMPHOMA TREATED WITH DOXORUBICIN-CONTAINING CHEMOTHERAPY WITH OR WITHOUT RADIOTHERAPY, Acta oncologica, 36(6), 1997, pp. 619-624
ORIGIN AND FUNCTION OF CIRCULATING CD44 IN NON-HODGKINS-LYMPHOMA
Authors: RISTAMAKI R JOENSUU H GRONVIRTA K SALMI M JALKANEN S
Citation: R. Ristamaki et al., ORIGIN AND FUNCTION OF CIRCULATING CD44 IN NON-HODGKINS-LYMPHOMA, The Journal of immunology, 158(6), 1997, pp. 3000-3008
ELEVATED SERUM CD44 LEVEL IS ASSOCIATED WITH UNFAVORABLE OUTCOME IN NON-HODGKINS-LYMPHOMA
Authors: RISTAMAKI R JOENSUU H LAPPALAINEN K TEERENHOVI L JALKANEN S
Citation: R. Ristamaki et al., ELEVATED SERUM CD44 LEVEL IS ASSOCIATED WITH UNFAVORABLE OUTCOME IN NON-HODGKINS-LYMPHOMA, Blood, 90(10), 1997, pp. 4039-4045
ORIGIN, FUNCTION, AND PROGNOSTIC-SIGNIFICANCE OF SOLUBLE CIRCULATING CD44
Authors: RISTAMAKI R JALKANEN S GRONVIRTA K SALMI M HAGBERG H KALKNER KM JOENSUU H
Citation: R. Ristamaki et al., ORIGIN, FUNCTION, AND PROGNOSTIC-SIGNIFICANCE OF SOLUBLE CIRCULATING CD44, European journal of cancer, 31A, 1995, pp. 789-789
CD44V6 EXPRESSION IN NON-HODGKINS-LYMPHOMA - AN ASSOCIATION WITH LOW HISTOLOGICAL GRADE AND POOR-PROGNOSIS
Authors: RISTAMAKI R JOENSUU H SODERSTROM KO JALKANEN S
Citation: R. Ristamaki et al., CD44V6 EXPRESSION IN NON-HODGKINS-LYMPHOMA - AN ASSOCIATION WITH LOW HISTOLOGICAL GRADE AND POOR-PROGNOSIS, Journal of pathology, 176(3), 1995, pp. 259-267
EFFECT OF TREATMENT ON THE PROGNOSTIC VALUE OF S-PHASE FRACTION IN NON-HODGKINS-LYMPHOMA
Authors: JOENSUU H RISTAMAKI R SODERSTROM KO JALKANEN S
Citation: H. Joensuu et al., EFFECT OF TREATMENT ON THE PROGNOSTIC VALUE OF S-PHASE FRACTION IN NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 12(10), 1994, pp. 2167-2175
SERUM CD44 IN MALIGNANT-LYMPHOMA - AN ASSOCIATION WITH TREATMENT RESPONSE
Authors: RISTAMAKI R JOENSUU H SALMI M JALKANEN S
Citation: R. Ristamaki et al., SERUM CD44 IN MALIGNANT-LYMPHOMA - AN ASSOCIATION WITH TREATMENT RESPONSE, Blood, 84(1), 1994, pp. 238-243
LYMPHOCYTE HOMING RECEPTOR (CD44) EXPRESSION IS ASSOCIATED WITH POOR-PROGNOSIS IN GASTROINTESTINAL LYMPHOMA
Authors: JOENSUU H RISTAMAKI R KLEMI PJ JALKANEN S
Citation: H. Joensuu et al., LYMPHOCYTE HOMING RECEPTOR (CD44) EXPRESSION IS ASSOCIATED WITH POOR-PROGNOSIS IN GASTROINTESTINAL LYMPHOMA, British Journal of Cancer, 68(2), 1993, pp. 428-432
Risultati: 1-9 |